Accord Healthcare

CAMCEVI

Manufacturer:

Accord Healthcare

Camcevi HCPCS:

J1952

HCPCS Code Descriptor:

Leuprolide injectable, camcevi, 1 mg

Category:

J Code

Camcevi NDCs:

69448-0014-63

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Route of Administration:

Subcutaneous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Camcevi:

CAMCEVI is an Oncology drug manufactured by Accord Healthcare and administered via the Subcutaneous route of administration. The J Code: J1952 is aligned to the drug CAMCEVI.

CAMCEVI is a gonadotropin releasing hormone (GnRH) agonist commonly used to treat advanced prostate cancer. Acting a powerful inhibitor of gonadotropin secretion, long term use of CAMCEVI (J1952) results in a drastic decrease in the amount of testosterone produced. CAMCEVI is used most commonly in men over the age of 65. Patient assistance is available through Camcevi.

ACCESS PRICING AND MORE BY REGISTERING

J1952 Added Date:

January 1, 2022

J1952 Effective Date:

October 1, 2022

J1952 Termination Date:

HCPCS Active

Camcevi billing and coding information can be found through Accord Healthcare at the link below:
Camcevi patient assistance information can be found through The Accordcares Co-Pay And Patient Assistance Programs at the URL: https://www.camcevi.com/support-resources/
CAMCEVI prescribing information can be found at the link below:
Information regarding CAMCEVI’s side effects can be found at MedlinePlus